MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cellsNabanita Mukherjee, Yiqun G. Shellman|Cell Death and Disease|2020Cited by 71
BH3 mimetics induce apoptosis independent of DRP-1 in melanomaNabanita Mukherjee, Yiqun G. Shellman|Cell Death and Disease|2018Cited by 27
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and AzacitidineChiara R. Dart, Yiqun G. Shellman|Pharmaceuticals|2021Cited by 5